How Indegene Uses “Hybrid” Go-To-Market Model to Help Orchestra Omnichannel Pharma Launches for Their Clients
Jan 12, 2024
auto_awesome
Explore the hybrid model blending face-to-face with digital in pharma launches. Uncover the reasons behind launch failures and the shift from Reach and Frequency model. Delve into the importance of channels vs. content and Indegene's TLO framework for optimization. Learn about building digital engagement models for healthcare professionals.
Hybrid omni-channel model integrates face-to-face and digital channels for enhanced HCP engagement.
Segmentation and personalized messaging are key for successful pharmaceutical product launches.
Deep dives
The Importance of Successful Launches in Pharma Marketing
Pharma marketers are intensifying their focus on successful product launches due to the high rate of launch failures in recent years, with over 60% not achieving their year two forecast. The evolving market dynamics and customer preferences necessitate a deeper understanding of what it takes to launch successfully. A key trend involves adopting a hybrid omni-channel model that integrates face-to-face interactions with digital approaches to enhance the healthcare professional (HCP) experience and improve reach and engagement.
Hybrid Omni-Channel Model Enhancing HCP Engagement
The hybrid omni-channel model, known as a hybrid omni-channel model, combines face-to-face and digital channels to align with HCP preferences and provide a tailored and integrated approach. By leveraging data on HCP preferences, the model aims to optimize content delivery, ensuring relevant and timely information that enhances the HCP experience. Unlike traditional approaches that segregated face-to-face and digital channels, the hybrid model emphasizes the importance of integrating various channels for effective HCP engagement.
Segmentation, Targeting, and Positioning for Effective Marketing
Effective pharmaceutical marketing begins with understanding the product opportunity, market dynamics, and customer behavior to create targeted segmentation strategies. By augmenting traditional data with insights on digital affinity and content preferences, marketers can tailor their messaging to resonate with HCPs. The segmentation, targeting, and positioning (STP) framework allows for precise alignment of product positioning with customer segments, enabling personalized and impactful communication strategies.
Challenges and Gaps in Launch Execution
A significant gap exists between planned strategies and actual execution in pharmaceutical product launches, particularly in areas like payer activation, label attainment, and HCP adoption. The evolving healthcare landscape demands a more agile and data-driven approach to bridge these execution gaps effectively. Monitoring key performance indicators, such as call frequency and content delivery, is crucial to optimizing launch strategies and ensuring alignment with market realities.
Pharma/AOR Executives: Make sure you grab a complimentary copy of our 3-Step Guide To Using the Netflix-like Content Hubs to Engage HCPs in 30-90 Days 👉 3-Step Free Guide
In this episode, Bozidar speaks with Nancy Phelan, senior VP at Indegene. They cover the following topics:
Hybrid model: Taking the best of face-to-face and powering it with digital
Discover new research on the 5 Reasons Why Most Launches Fail: There is a gap between what you plan and what you are executing
Why doesn’t the classical Reach and Frequency model work anymore?
Channels vs. Content: Can we view them separately?
Indegene’s TLO framework: Test learn and optimize approach
Digital rep equivalent: Building a model for HCPs' digital engagement
“Pharma Launch Secrets” is a podcast by Evermed and hosted by CEO Bozidar Jovicevic. We host direct, actionable conversations with world-leading pharma launch experts and help you stay up-to-date with the latest trends and strategies to help you launch your product successfully.